Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Aeglea BioTherapeutics Inc. (AGLE)

7.74   -0.33 (-4.09%) 02-21 10:59
Open: 8.09 Pre. Close: 8.07
High: 8.09 Low: 7.72
Volume: 12,284 Market Cap: 224M
Aeglea BioTherapeutics Inc is a biopharmaceutical company committed to developing enzyme-based therapeutics in the field of amino acid metabolism, which will transform the lives of patients with inborn errors of metabolism and cancer.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.249 - 8.296 8.296 - 8.339
Low: 7.922 - 7.973 7.973 - 8.019
Close: 7.996 - 8.078 8.078 - 8.153

Technical analysis

as of: 2020-02-21 10:24:37 AM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 9.93     One year: 11.60
Support: Support1: 7.38    Support2: 6.69
Resistance: Resistance1: 8.50    Resistance2: 9.93
Pivot: 8.08
Moving Average: MA(5): 8.14     MA(20): 7.88
MA(100): 7.84     MA(250): 7.63
MACD: MACD(12,26): 0.13     Signal(9): 0.12
Stochastic oscillator: %K(14,3): 79.37     %D(3): 81.09
RSI: RSI(14): 52.88
52-week: High: 9.10  Low: 5.99  Change(%): -5.2
Average Vol(K): 3-Month: 5578  10-Days: 3330

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
AGLE has closed below upper band by 49.2%. Bollinger Bands are 18.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 08 Apr 2019 17:06:37 +0000
Mid-Day Market Update: Crude Oil Up 1.7%; BP Prudhoe Bay Royalty Trust Shares Plunge

Wed, 06 Feb 2019 14:12:49 +0000
Health Care Sector Update for 02/06/2019: NVLN, AGLE, VNDA, JNJ, PFE, MRK, ABT, AMGN

Wed, 06 Feb 2019 08:50:14 +0000
Health Care Sector Update for 02/06/2019: XNCR,MGNX,NVLN,AGLE

Wed, 06 Feb 2019 07:02:46 +0000
Health Care Sector Update for 02/06/2019: MGNX,NVLN,AGLE

Tue, 02 Oct 2018 08:19:34 +0000
After Hours Most Active for Oct 2, 2018 : MSFT, FOXA, AGLE, FB, ERI, EMB

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 28.99
Shares Float (M) 16.33
% Held by Insiders 5.17
% Held by Institutions 81.50
Shares Short (K) 202
Shares Short P. Month (K)

Stock Financials

EPS -2.410
Book Value (p.s.) 2.760
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -53.8
Return on Equity (ttm) -99.9
Qtrly Rev. Growth
Gross Profit (p.s.) -1.132
Sales Per Share
EBITDA (p.s.) -2.530
Qtrly Earnings Growth
Operating Cash Flow (M) -56.60
Levered Free Cash Flow (M) -31.87

Stock Valuations

P/E -3.36
P/E Growth Ratio
P/BV 2.93
P/CF -4.14

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.